BNET Industries

Market Cap:$26.9K
  • Public
  • US
Dow Jones Description

Embryo Development Corporation is a Delaware corporation (the "Company" or "Embryo"), which was organized in March 1995 to develop, acquire, manufacture and market various bio- medical devices. The Company has not derived any significant revenues since its inception. The Company was a licensee to seven (7) license agreements (the "License Agreements") and two (2) royalty sharing agreements (the "Royalty Sharing Agreements") with Dr. Lloyd Marks which provided for the exclusive license of seven medical devices and the sharing of royalties of two (2) medical devices, all of which had been developed by Dr. Marks ("Marks Medical Devices"). As of January 2001, all of these licenses had been terminated. The termination of the above license agreements followed a determination by management to conserve capital and that the products licensed could not profitably be developed and commercially marketed by the Company at this time. The Company holds patents to five (5) other medical devices and was the exclusive licensee of one (1) medical device in the areas of emergency medical equipment and peritoneal dialysis warming devices. Although the Company holds the patents and rights to these products, management does not believe that these products have any viable marketability at this time.

Contact Information

305 Madison Avenue, Suite 4510

New York, New York 10165

2128080607

NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510

News & Analysis

embryo development corp. - All News and Analysis

  • Embryo Development Corp. makes announcement

    - 1997-02-10

    NEW YORK--BUSINESS WIRE--Feb. 10, 1997--Embryo Development Corp. (NASDAQ:EMBR) announced today that the company through its majority owned subsidiary, Hydrogel Design Systems Inc., has simultaneously entered into and closed on two asset purchase agreements pursuant to which it has acquired substantially all of the assets from two related entities, Novatech Inc....

    Tags: asset, Business Wire, Embryo Development Corp.

advertisement
     EMBR $0.00 0.00 (0.00% )
Average Volume 37,889
Shares Outstanding 6.75M
Market Cap 28.3K
Year High 0.065
Year Low 0.0002
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement